Business wants a WTO trade deal to end tariffs on chemicals
Japan's Kobe Steel will start commercial production of aluminum sheets used for car bodies in China in the first quarter of 2017, company spokesman Tatsuro Kanoh said Monday.
Kobe Steel's wholly owned subsidiary Kobelco Automotive Aluminum Rolled Products China started sample production in April 2016, to be tested by automakers worldwide ahead of commercial production.
"We have started sample shipments and are awaiting certification of automakers in Japan, Europe and North America," Kanoh said.
The Chinese plant, located in Tianjin Xiqing Economic Development Area in Tianjin city, has a nameplate capacity to produce 100,000 mt/year in total of 5000 and 6000 series aluminum alloy sheets, used for outer and inner panels of car body sheets.
Kobe Steel is the leading manufacturer of aluminum auto sheets in Japan, with a capacity of 30,000 mt/month sheet production in Moka city in Tochigi prefecture near Tokyo.
The company plans to launch sheet production in the US in 2017.
Market research firm Technavio said Friday the global aluminum market for automotive is expected to see a compound annual growth rate of 4.5% in the 2016-2020 period, on the back of demand for lightweight cars.
2026-10-23
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Medicare’s $50 GLP-1 Door Opens: Weight-Loss Drug Demand Just Got Bigger
-
China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
-
Refrigerant Prices Peak! Domestic Quotas Tighten, U.S. and U.K. Policies Add Fuel to the Fire
-
Canada Issues Non-Compliance Notice to Dr. Reddy’s on Semaglutide Generic
-
FDA Warning Letters Put GMP Back in Focus
-
FDA Fast-Tracks U.S. Drug Manufacturing
-
A Fake Email Drains RMB 12 Million: Asia’s Waterproof Giant’s Overseas ‘Payment Heist’ Exposes the Fatal Blind Spot of Chinese Corporate Globalization
-
FDA Names Veteran Oncology Regulator Pazdur as Director of Drug Review Center
-
After Semaglutide Patent Expiry in India, the Price System Has Been Restructured as More Than 40 Drugmakers Enter the Competition
-
Brazil Expands Chemical Tax Breaks as India’s Crop Protection Industry Warns of a 25% Cost Increase
Recommend Reading
-
FDA Lifts Administrative Stay, Restoring Red No. 3 Ban Timeline for Food and Ingested Drugs
-
G20 Pushes Fertilizer Access as Food-Security Risk Rises
-
Syngenta Caught in Trade Crossfire
-
India Prepares New Seed and Pesticide Laws
-
FDA Tracks Industry Dye Removal
-
Acetic Acid Market Trends Remain Strong
-
November Adipic Acid Market Continues to Weaken, Reaching New Lows
-
Premium Global Chemical Sourcing Requests (3-5Aug, 2026)
-
Recent EVA Market Trend Weakly in China
-
Phosphoric Acid Market Trends in November Show a Strong Uptrend